drugset / Trial / NCT00424671
Effect of Moderate Hepatic Impairment on the Pharmacokinetics and Metabolism of a Single Dose of Licarbazepine
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will assess the influence of moderate hepatic impairment on the pharmacokinetics of licarbazepine after single oral administration in healthy subjects and in subjects with stable impaired hepatic function.
Timeline
- Start
- 2006-11
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Licarbazepine | Small molecule | 1000 mg | Oral |
Indications
No indication recorded.